BIOX icon

Bioceres Crop Solutions

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 60%
Negative

Negative
Seeking Alpha
12 days ago
Bioceres Lenders Claim Default, And Dilution Risks Are Higher Than Ever
Bioceres reported 1Q26 results with continued revenue declines but improved gross margins and significant OpEx reductions, boosting profitability. BIOX faces severe financial risks, including default claims and lawsuits to accelerate over $100 million in debt, which it cannot cover with current cash. Equity holders face high dilution risk from convertible notes and potential asset sales, as the company cannot be evaluated as a going concern.
Bioceres Lenders Claim Default, And Dilution Risks Are Higher Than Ever
Neutral
Seeking Alpha
19 days ago
Bioceres Crop Solutions Corp. (BIOX) Q1 2026 Earnings Call Transcript
Bioceres Crop Solutions Corp. ( BIOX ) Q1 2026 Earnings Call November 13, 2025 8:30 AM EST Company Participants Paula Savanti - Head of Investor Relations Federico Trucco - Executive Chairman & CEO Conference Call Participants Austin Moeller - Canaccord Genuity Corp., Research Division Presentation Operator Good morning all, and thank you for joining us on today's Bioceres Crop Solutions Fiscal First Quarter 2026 Financial and Operational Results. My name is Drew, and I'll be the operator on the call today.
Bioceres Crop Solutions Corp. (BIOX) Q1 2026 Earnings Call Transcript
Negative
Zacks Investment Research
20 days ago
Bioceres Crop (BIOX) Reports Q1 Loss, Lags Revenue Estimates
Bioceres Crop (BIOX) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.09 per share a year ago.
Bioceres Crop (BIOX) Reports Q1 Loss, Lags Revenue Estimates
Neutral
Business Wire
20 days ago
Bioceres Crop Solutions Reports Fiscal First Quarter 2026 Financial and Operational Results
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal first quarter ended September 30, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons.
Bioceres Crop Solutions Reports Fiscal First Quarter 2026 Financial and Operational Results
Neutral
Business Wire
1 month ago
Bioceres Crop Solutions to Host Fiscal First Quarter 2026 Financial Results Conference Call on Thursday, November 13, 2025 at 8:30 a.m. Eastern Time
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Thursday, November 13, 2025 at 8:30 a.m. Eastern Time to discuss its results for the fiscal first quarter ended September 30, 2025. A press release detailing these results will be.
Bioceres Crop Solutions to Host Fiscal First Quarter 2026 Financial Results Conference Call on Thursday, November 13, 2025 at 8:30 a.m. Eastern Time
Neutral
Business Wire
2 months ago
Bioceres Crop Solutions and Colorado Wheat Research Foundation Partner to Advance Climate-Resilient HB4® Wheat in the U.S.
ROSARIO, Argentina & FORT COLLINS, Colorado--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) and the Colorado Wheat Research Foundation (CWRF) today announced a strategic collaboration to jointly develop and commercialize HB4® wheat in the United States. The agreement combines Bioceres' proprietary HB4® technology, with CWRF's leadership in U.S. wheat innovation to create a next generation wheat production system. This system is designed to integrate climate resilience and environ.
Bioceres Crop Solutions and Colorado Wheat Research Foundation Partner to Advance Climate-Resilient HB4® Wheat in the U.S.
Negative
Seeking Alpha
2 months ago
Bioceres At Its Worst Juncture, Equity Dilution Seems Very Possible
Bioceres reported a disastrous year with sales down 30%, margins collapsing, and large unexplained debt losses, resulting in a $60 million net loss. The company faces severe liquidity and capital allocation risks, with high-interest debt, unclear disclosures, and increased dilution risk from convertible notes. Management and board instability, along with poor reporting transparency, further undermine confidence in Bioceres' ability to navigate its challenges.
Bioceres At Its Worst Juncture, Equity Dilution Seems Very Possible
Negative
Seeking Alpha
2 months ago
Bioceres Crop Solutions: Waiting For Gross Profit To Turn (Downgrade)
Downgrade Bioceres Crop Solutions Corp. to Hold due to Argentina's volatile currency, credit constraints, and a challenging shift in the seed sales model. Recent results show sharply lower revenues, deeper losses, but disciplined cash management, and a focus on cost reductions going forward. Valuation sits at 3.5x gross profit and 8.5–11x EV/EBITDA, but earnings risk and potential dilution remain high.
Bioceres Crop Solutions: Waiting For Gross Profit To Turn (Downgrade)
Neutral
Seeking Alpha
2 months ago
Bioceres Crop Solutions Corp. (BIOX) Q4 2025 Earnings Call Transcript
Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q4 2025 Earnings Call September 9, 2025 8:30 AM EDT Company Participants Paula Savanti - Head of Investor Relations Federico Trucco - Executive Chairman & CEO Conference Call Participants Kristen Owen - Oppenheimer & Co. Inc., Research Division Benjamin Klieve - Lake Street Capital Markets, LLC, Research Division Austin Moeller - Canaccord Genuity Corp., Research Division Brian Kemp Dolliver - Brookline Capital Markets, LLC, Research Division Presentation Operator Welcome all to the Bioceres Crop Solutions Fiscal Fourth Quarter and Full Year 2025 Financial Results. My name is Drew, and I'll be the operator on the call today.
Bioceres Crop Solutions Corp. (BIOX) Q4 2025 Earnings Call Transcript
Neutral
Business Wire
2 months ago
Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2025 Financial and Operational Results
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal fourth quarter ended June 30, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in t.
Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2025 Financial and Operational Results